Shanghai, China

Guansong Wu

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guansong Wu. Retrieved from https://idiyas.com/inventor/guansong-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guansong Wu: A Pioneer in Huperzine A Derivatives

Introduction

Guansong Wu, based in Shanghai, China, is a notable inventor recognized for his contributions to medicinal chemistry. With a focus on Huperzine A derivatives, his work has the potential to advance therapeutic techniques significantly.

Latest Patents

Wu holds one patent titled "Huperzine A derivatives, their preparation and their use." This patent demonstrates innovative approaches in utilizing these compounds for various applications, reflecting his expertise in pharmaceuticals.

Career Highlights

He is currently employed at the Chinese Academy of Sciences, where he contributes to cutting-edge research that bridges chemistry and medicine. His work showcases a dedication to exploring new health solutions through scientific innovation.

Collaborations

Throughout his career, Wu has collaborated with esteemed colleagues such as Dayuan Zhu and Xican Tang. Together, they drive forward research efforts that enhance the field of medicinal chemistry and broaden the impact of their discoveries.

Conclusion

Guansong Wu exemplifies the spirit of innovation in the realm of medicinal chemistry. His focus on Huperzine A derivatives not only highlights his ingenuity but also underscores the importance of collaborative efforts in scientific exploration. As he continues his work at the Chinese Academy of Sciences, the potential for future breakthroughs remains significant.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…